Subcutaneously Administered MD-18 for the Treatment of Obesity and Diabetes

NCT06739707 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: MD-18
DRUG: Placebo

Sponsor

Cohen Global, Ltd.